Vera Therapeutics, Inc.

By person

22 insiders · 238 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ENRIGHT PATRICK G

Director

$32.53M (8)

—

+$32.53M

6,699,069

9.30%

$235.24M

+415.7%

Longitude Capital Partners IV, LLC entity

10% owner

$27.00M (3)

—

+$27.00M

4,810,879

6.68%

$168.94M

—

Katabi Maha

Director

$13.00M (2)

$34.10M (6)

−$21.10M

5,708,763

7.92%

$200.47M

+64.7%

Fordyce Marshall

PRESIDENT AND CEO

—

$19.72M (84) scheduled

−$19.72M

235,244

0.3264%

$8.26M

+5,703%

Sofinnova Venture Partners X, L.P. entity

10% owner

$14.00M (3)

—

+$14.00M

3,467,156

4.81%

$121.75M

—

COMMODORE CAPITAL LP entity

10% owner

$6.80M (1)

$18.90M (1)

−$12.10M

4,400,000

6.11%

$154.51M

−12.0%

EMSTER KURT VON

Director

$8.71M (2)

—

+$8.71M

2,978,059

4.13%

$104.58M

—

Abingworth LLP

10% owner

$8.50M (1)

—

+$8.50M

2,960,231

4.11%

$103.95M

—

Grant Sean

CHIEF FINANCIAL OFFICER

$251.00K (6)

$4.90M (20) scheduled

−$4.65M

119,181

0.1654%

$4.19M

+1,548%

SEIDENBERG BETH C

Director

$4.32M (19)

$1.42M (5) scheduled

+$2.90M

1,478,717

2.05%

$51.93M

—

Young Joseph R

SVP, FINANCE, CHIEF ACCT OFFCR

$40.00K (1)

$2.10M (7) scheduled

−$2.06M

80,754

0.1121%

$2.84M

+882.3%

Curley Joanne

Chief Development Officer

—

$1.82M (48) scheduled

−$1.82M

26,962

0.0374%

$946.79K

+0.5%

Turner William D.

Chief Regulatory Officer

—

$1.45M (4) scheduled

−$1.45M

45,313

0.0629%

$1.59M

—

Carlyle Group Inc. entity

10% owner

—

$201.03K (3) scheduled

−$201.03K

2,960,231

4.11%

$103.95M

0.0%

JOHNSON DAVID LEE

Chief Operating Officer

—

$108.28K (1)

−$108.28K

45,727

0.0635%

$1.61M

+3,152%

Carter Jason S

Chief Legal Officer

—

$107.50K (1)

−$107.50K

49,136

0.0682%

$1.73M

—

Brenner Robert

Chief Medical Officer

—

$90.31K (1)

−$90.31K

50,947

0.0707%

$1.79M

+4,153%

Skelton Laurence Matthew

Chief Commercial Officer

—

$66.42K (1)

−$66.42K

64,218

0.0891%

$2.26M

+40.2%

Lin Celia

Chief Medical Officer

—

$24.82K (1) scheduled

−$24.82K

11,010

0.0153%

$386.62K

—

Boman Nancy Lee

Chief Regulatory Officer

—

44,987

0.0624%

$1.58M

—

Wright-Mitchell Jane

Chief Legal Officer

—

42,403

0.0588%

$1.49M

—

Cheng Andrew

Director

—

17,488

0.0243%

$614.11K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Young Joseph R

11 Sep 2026

SVP, FINANCE, CHIEF ACCT OFFCR

Exercised, kept

5,000

$3.94

$19.70K

Young Joseph R

13 Mar 2026

SVP, FINANCE, CHIEF ACCT OFFCR

Exercised, kept

10,000

$3.94

$39.40K

Young Joseph R

13 Nov 2025

SVP, FINANCE, CHIEF ACCT OFFCR

Exercised, kept

10,000

$3.94

$39.40K

Fordyce Marshall

19 Dec 2024

PRESIDENT AND CEO

Exercised, kept

57,661

$2.90

$167.03K

Fordyce Marshall

29 Dec 2023

President and CEO

Exercised, kept

13,000

$2.90

$37.66K

Fordyce Marshall

29 Dec 2023

President and CEO

Exercised, kept

516

$2.32

$1.20K

Young Joseph R

5 Jul 2023

SVP, Finance, Chief Acct Offcr

Exercised, kept

10,000

$3.94

$39.40K

Fordyce Marshall

16 Nov 2022

President and CEO

Exercised, kept

60,000

$2.90

$173.81K

Fordyce Marshall

16 Nov 2022

President and CEO

Exercised, kept

5,153

$2.32

$11.94K

Show all 238 transactions →

By person

Individual transactions

What was left out